2025
Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention
Khati A, Copenhaver M, Xu R, Altice F, Wickersham J, Gautam K, Paudel K, Shrestha R. Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention. Journal Of Substance Use And Addiction Treatment 2025, 173: 209693. PMID: 40222706, PMCID: PMC12477707, DOI: 10.1016/j.josat.2025.209693.Peer-Reviewed Original ResearchOpioid-dependent PWIDPre-exposure prophylaxisPrEP prescriptionPrEP useInjected drugsOral pre-exposure prophylaxisBehaviours related to sexFollow-up periodOpioid dependencePrEP continuum of careAssociated with higher persistenceFactors associated with persistenceMultivariable ordinal logistic regressionOpioid-dependent peopleDrug useAssess sociodemographic characteristicsPrEP persistenceRelated to sexHIV outbreakContinuum of careEarly 40sParticipantsPrEP continuumHIV preventionHIV
2013
Optimizing Care for HIV-Infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities
Meyer JP, Althoff AL, Altice FL. Optimizing Care for HIV-Infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities. Clinical Infectious Diseases 2013, 57: 1309-1317. PMID: 23797288, PMCID: PMC3792721, DOI: 10.1093/cid/cit427.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHuman immunodeficiency virusSubstance use disordersAntiretroviral therapyHealthcare disparitiesInitiation of ARTComorbid substance use disorderHIV treatment outcomesContinuum of careEvidence-based strategiesEvidence-based approachHIV specialistsHIV careHIV diagnosisImmunodeficiency virusTreatment outcomesUse disordersSubstance useCareDiagnosisDrugsOutcomesDisparitiesNegative outcomesTherapyEpidemiology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply